Postnatal treatment approaches to hemolytic disease of the fetus and newborn vary significantly worldwide, highlighting the ...

This rate is higher than observed in children treated with a beta-lactamase resistant agent, although the associated risk estimate reached statistical significance (pooled OR: 2.39 [95% CI ...